2Chunlei F,Xingde W,Ying Q,et al. Effect of curcumin on the expression of LDL receptor in mouse macrophages [ J ]. J Ethnopharmacol,2006,105 ( 1 - 2 ) :251 - 4.
3Weijia K,Jing W,Parveen A,et al. Berberine is a novel cholesterol-loweringdrug working through a unique mechanism distinct from statins [ J ]. Nat Med,2004,10 : 1344 - 51.
6Mas R,Cas T G,Fer N D J,et al. Long-term effects of policosanol on obese patients with Type Ⅱ Hypercholesterolemia[ J]. Asia Pac J Clin Nutr,2004,13 (Suppl) :S102.
7Mirkin A, Mas R, Mar T M,et al. Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women[ J ]. Int J Clin Pharmacol Res ,2001,21 (1) :31 -41.
8Castano G, Mas R, For nandez L,et al. Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly prtients with type Ⅱ hypercholesterolaemia [ J ]. Drugs Aging, 2003,20 (2) :153 - 63.
9Dev K S, Li L, Porter T D. Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase[ J]. J Pharmacol Exp Therap Fast Forw,2006 ,DOI: 10. 1124/jpet. 106. 107144.
10McCarty M F. Policosanol safely down-regulates HMG-CoA reductase-potential as a component of the Esselstyn regimen [ J ]. Med Hypotheses ,2002,59 ( 3 ) : 268 - 79.
